Notice of Intent to issue a Sole Source Award to generate and optimize high-affinity nucleic acid aptamers capable of semi-quantitative detection of TFV-DP and/or TFV for use in both plate-based assays and POC platforms.

PresolicitationNo Set AsideActive

Key Takeaways

  • Set-aside for No Set Aside businesses
  • Work to be performed in ATLANTA, GA
  • Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
  • Advance notice of upcoming solicitation

Contract Details

Notice ID
75D30126R73457
Opportunity Type
Presolicitation
Sub-Agency
CENTERS FOR DISEASE CONTROL AND PREVENTION
Office
CDC OFFICE OF ACQUISITION SERVICES
Posted Date
Monday, May 18, 2026
Response Deadline
Tuesday, June 2, 2026
PSC Code
AJ12
Set-Aside
No Set Aside
Place of Performance
ATLANTA, GA, 30333
Status
Active

Description

The Centers for Disease Control and Prevention Division of HIV Prevention (DHP)/Laboratory Branch intends to award a sole source Firm-fixed-price purchase order to the University of North Carolina at Chapel Hill, Department of Chemistry to generate and optimize high-affinity nucleic acid aptamers capable of semi-quantitative detection of TFV-DP and/or TFV for use in both plate-based assays and POC platforms. This contract action is for commercial services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 12.102-1. NAICS 541715 - Medical Research and Development Laboratories or Services (except Biotechnology and Nanotechnology Research and Development). UNC was identified as uniquely qualified due to its role as a co-inventor of the FT

Why This Opportunity Matters

HEALTH AND HUMAN SERVICES, DEPARTMENT OF is actively seeking qualified contractors for research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) with a set-aside for No Set Aside businesses in ATLANTA, GA. This set-aside designation means eligible businesses face reduced competition from larger firms.